Kevin Brady

1.3k total citations
29 papers, 591 citations indexed

About

Kevin Brady is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Kevin Brady has authored 29 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Immunology. Recurrent topics in Kevin Brady's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (4 papers) and Immune Cell Function and Interaction (4 papers). Kevin Brady is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (4 papers) and Immune Cell Function and Interaction (4 papers). Kevin Brady collaborates with scholars based in United Kingdom, United States and Switzerland. Kevin Brady's co-authors include Paul N. Moynagh, Bryan D. Griffin, Jens Niewoehner, Daniel O’Toole, Per‐Ola Freskgård, Christian Klein, Laurence B. Peterson, Linda S. Wicker, Marcin Ł. Pękalski and Sarah Howlett and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Biochemical Journal.

In The Last Decade

Kevin Brady

28 papers receiving 572 citations

Peers

Kevin Brady
Wataru Hirose Japan
Károly Szekeres United States
Olivier Defert Belgium
Michael Hansbury United States
Jingshu Tang China
Anne Gardin Switzerland
R D Ye United States
Wan Li China
Takazumi Taniguchi Japan
Gabriele Hübinger Germany
Wataru Hirose Japan
Kevin Brady
Citations per year, relative to Kevin Brady Kevin Brady (= 1×) peers Wataru Hirose

Countries citing papers authored by Kevin Brady

Since Specialization
Citations

This map shows the geographic impact of Kevin Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Brady more than expected).

Fields of papers citing papers by Kevin Brady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Brady. The network helps show where Kevin Brady may publish in the future.

Co-authorship network of co-authors of Kevin Brady

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Brady. A scholar is included among the top collaborators of Kevin Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Brady. Kevin Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cauvin, Annick, Kevin Brady, Joy Cavagnaro, & C. Marc Luetjens. (2024). Evaluation of the effect of rozanolixizumab on pregnancy outcomes and pre- and postnatal development in cynomolgus monkeys. Reproductive Toxicology. 132. 108823–108823. 2 indexed citations
2.
Gaiser, Carine, et al.. (2023). A Perfused In Vitro Human iPSC-Derived Blood–Brain Barrier Faithfully Mimics Transferrin Receptor-Mediated Transcytosis of Therapeutic Antibodies. Cellular and Molecular Neurobiology. 43(8). 4173–4187. 13 indexed citations
3.
Bolleddula, Jayaprakasam, Kevin Brady, Gerard Bruin, et al.. (2022). Absorption, Distribution, Metabolism, and Excretion of Therapeutic Proteins: Current Industry Practices and Future Perspectives. Drug Metabolism and Disposition. 50(6). 837–845. 24 indexed citations
4.
Weber, Felix, Bernd Bohrmann, Jens Niewoehner, et al.. (2018). Brain Shuttle Antibody for Alzheimer’s Disease with Attenuated Peripheral Effector Function due to an Inverted Binding Mode. Cell Reports. 22(1). 149–162. 66 indexed citations
5.
Peterson, Laurence B., Sarah Howlett, Marcin Ł. Pękalski, et al.. (2018). A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease. Journal of Autoimmunity. 95. 1–14. 104 indexed citations
6.
Brady, Kevin & Rob Webster. (2012). Disposition of Biologics. Advances in pharmacology. 63. 257–277. 6 indexed citations
7.
Roberts, Lee R., Kevin Brady, Lijin Feng, et al.. (2012). Kappa agonist CovX-Bodies. Bioorganic & Medicinal Chemistry Letters. 22(12). 4173–4178. 5 indexed citations
8.
Brady, Kevin, Frances Burden, Hubert Denise, et al.. (2011). In Vitro Characterization of the Activity of PF-05095808, a Novel Biological Agent for Hepatitis C Virus Therapy. Antimicrobial Agents and Chemotherapy. 56(3). 1364–1375. 10 indexed citations
9.
10.
11.
Griffin, Bryan D., et al.. (2005). The Synthetic Cannabinoid R(+)WIN 55,212-2 Inhibits the Interleukin-1 Signaling Pathway in Human Astrocytes in a Cannabinoid Receptor-independent Manner. Journal of Biological Chemistry. 280(43). 35797–35806. 56 indexed citations
12.
Missailidis, Sotiris & Kevin Brady. (2004). Characterization of Antibody–Antigen Interactions by Fluorescence Spectroscopy. Humana Press eBooks. 248. 431–442. 4 indexed citations
13.
Benedetti, Fabio, Federico Berti, Kevin Brady, et al.. (2003). An Unprecedented Catalytic Motif Revealed in the Model Structure of Amide Hydrolyzing Antibody 312d6. ChemBioChem. 5(1). 129–131. 6 indexed citations
14.
Cross, Simon, et al.. (2002). New variation on a theme: structure and mechanism of action of hydrolytic antibody 7F11, an aspartate rich relation of catalytic antibodies 17E8 and 29G11. Journal of Immunological Methods. 269(1-2). 173–195. 1 indexed citations
15.
Brady, Kevin, Stephen Fitzgerald, Sigurður Ingvarsson, Carl Borrebaeck, & Paul N. Moynagh. (2001). CD40 Employs p38 MAP Kinase in IgE Isotype Switching. Biochemical and Biophysical Research Communications. 289(1). 276–281. 15 indexed citations
16.
Murray, Andrea, Richard Smith, Kevin Brady, et al.. (2001). Generation and Refinement of Peptide Mimetic Ligands for Paratope-Specific Purification of Monoclonal Antibodies. Analytical Biochemistry. 296(1). 9–17. 12 indexed citations
17.
Brady, Kevin, et al.. (1999). Production and characterization of an anti-(MUC1 mucin) recombinant diabody. Cancer Immunology Immunotherapy. 48(1). 29–38. 19 indexed citations
18.
Spencer, Daniel I. R., Sotiris Missailidis, G. Denton, et al.. (1999). Structure/activity studies of the anti‐MUC1 monoclonal antibody C595 and synthetic MUC1 mucin‐core‐related peptides and glycopeptides. Biospectroscopy. 5(2). 79–91. 21 indexed citations
19.
Brady, Kevin, et al.. (1997). Lack of relationship between TNF-α-stimulated endothelin-1 production and loss of barrier function in endothelial cells. Biochemical Society Transactions. 25(1). 141S–141S. 1 indexed citations
20.
Paoni, Nicholas F., Canio J. Refino, Kevin Brady, et al.. (1992). Involvement of residues 296–299 in the enzymatic activity of tissue-type plasminogen activator. Protein Engineering Design and Selection. 5(3). 259–266. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wataru Hirose Breakdown of academic impact, for papers by Károly Szekeres Breakdown of academic impact, for papers by Olivier Defert Breakdown of academic impact, for papers by Michael Hansbury Breakdown of academic impact, for papers by Jingshu Tang Breakdown of academic impact, for papers by Anne Gardin Breakdown of academic impact, for papers by R D Ye Breakdown of academic impact, for papers by Wan Li Breakdown of academic impact, for papers by Takazumi Taniguchi Breakdown of academic impact, for papers by Gabriele Hübinger
Rankless by CCL
2026